Medexus Pharmaceuticals Inc. (OTCMKTS:PDDPF – Get Free Report) fell 33.5% during mid-day trading on Monday . The company traded as low as $2.11 and last traded at $2.14. 39,966 shares changed hands during mid-day trading, an increase of 818% from the average session volume of 4,355 shares. The stock had previously closed at $3.22.
Medexus Pharmaceuticals Price Performance
The business has a 50-day simple moving average of $2.14 and a 200-day simple moving average of $2.14.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals, Inc operates as a pharmaceutical company. It provide healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The company products include Rasuvo, Metoject and Rupall. Medexus was founded by Sylvain Chretien in January 2008 and is headquartered in Verdun, Canada.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- About the Markup Calculator
- Should You Invest in Treasury Bills?
- Why Invest in High-Yield Dividend Stocks?
- Analysts Think There’s Still Time to Get in on Edgewise, Up 332%
- The How And Why of Investing in Oil Stocks
- 3 Stocks Raising Dividends 4X Higher Than Inflation
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
